about
Progression and metastasis of lung cancerThe Janus Face of Death Receptor Signaling during Tumor ImmunoeditingImplications of Hypoxia in Breast Cancer Metastasis to BoneBone antiresorptive agents in the treatment of bone metastases associated with solid tumours or multiple myelomaMinireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios?Effects of de-escalated bisphosphonate therapy on bone turnover biomarkers in breast cancer patients with bone metastases.Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond.Bone-targeted agents in the treatment of lung cancer.Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatment.Isoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells.RANK and RANK ligand expression in primary human osteosarcoma.Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cellsHigh fat diet increases melanoma cell growth in the bone marrow by inducing osteopontin and interleukin 6Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis.Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions.Metformin inhibits RANKL and sensitizes cancer stem cells to denosumab.Interplay between low plasma RANKL and VDR-FokI polymorphism in lumbar disc herniation independently from age, body mass, and environmental factors: a case-control study in the Italian population.AR Expression in Breast Cancer CTCs Associates with Bone Metastases.NF-κB, the Importance of Being Dynamic: Role and Insights in Cancer.RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer
P2860
Q28066865-D725AD68-44AA-442F-9734-2E8054752B52Q28070036-6985C17C-7C85-42D9-9EEF-20CECF4E9BDDQ28077444-2B18148F-6B61-4CB8-8695-8D619EDA5134Q28081996-6B39E883-4844-4A3C-87B9-7E174283693CQ33631557-A1932120-CBE2-430C-A34F-2C04DFC8239AQ34325491-22CAD042-CBC0-4BC6-B504-D6AE810816EEQ34366449-08633F14-4897-4475-9407-F13C65923BA7Q35780792-21282C98-8015-403E-8236-A5B88C8FE448Q36067243-234E7992-3528-4B2D-BD22-344D758E7338Q36426121-E8ACA64C-071E-4A81-A361-FFB700DB2B9FQ37179783-ABE980BE-365A-45B6-ADB4-BC02471368BAQ37269535-33FA8801-9FE8-40B2-97C1-0E061158A27DQ37295749-EC66BA12-9446-46AA-BA0D-7F1803374BD3Q38787494-F6756B0F-C367-4152-93A5-AB4B0D81F06AQ42135817-1F509B69-6711-4F75-A8AD-E0458257DDC1Q42508259-6A8327A5-ADEF-44E6-9D94-CA841E2FBF39Q48147981-2697CCA7-B4FF-4136-BED6-E40ADBCC0554Q49913672-BE9F2DB9-3221-41FB-8569-E83F45051C49Q52315473-BA4FDA05-EF92-4025-8C16-4B00BE81921BQ56892940-8DD24CA8-AD9F-4B7E-8365-084F0669643F
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeting RANKL in metastasis
@ast
Targeting RANKL in metastasis
@en
Targeting RANKL in metastasis
@nl
type
label
Targeting RANKL in metastasis
@ast
Targeting RANKL in metastasis
@en
Targeting RANKL in metastasis
@nl
prefLabel
Targeting RANKL in metastasis
@ast
Targeting RANKL in metastasis
@en
Targeting RANKL in metastasis
@nl
P2860
P3181
P356
P1433
P1476
Targeting RANKL in metastasis
@en
P2093
Ingunn Holen
William C Dougall
P2860
P2888
P3181
P356
10.1038/BONEKEY.2014.14
P407
P577
2014-01-01T00:00:00Z
P5875
P6179
1016969441